Share This Article:

Clinical Characteristics of Invasive Methicillin-Resistant Staphylococcus aureus at General Hospital in the Central Region of Japan from July 2014 to June 2015

Full-Text HTML XML Download Download as PDF (Size:246KB) PP. 9-14
DOI: 10.4236/jbm.2015.39002    1,871 Downloads   2,079 Views  


Methicillin-resistant Staphylococcus aureus is crucial pathogen caused severe invasive infection disease. This study was conducted to find out the prevalence and antimicrobial susceptibility pattern of invasive Methicillin-resistant Staphylococcus aureus isolates at general hospital in the central region of Japan from July 2014 to June 2015. Methicillin-resistant Staphylococcus aureus was identified by standard laboratory procedure. Antimicrobial susceptibility testing was performed by micro dilution assay according to CLSI recommendation. Invasive Methicillin-resistant Staphylococcus aureus disease was defined as isolation of bacteria from a normally sterile body site. One hundred seventy-one methicillin-resistant Staphylococcus aureus were isolated among which 95 (55.6%) were from inpatient and 76 (44.4%) were from outpatient. The age incidence of (0 - 1) years, (1 - 10) years, (11 - 40) years, (41 - 60) years and >60 years age groups were 18 (10.5%), 41 (24.0%), 15 (8.8%), 5 (2.9%), and 92 (53.8%) respectively. There was significant difference of age distribution between invasive and noninvasive disease in 0 - 1 years group and 11 - 40 years age group. Positive samples were received mostly from the pediatrics (56/32.7%), respiratory medicine (25/14.6%) and general medicine (25/14.6%). We also found the significant differences of department between invasive and noninvasive disease in pediatrics, dermatology, and surgery. Arbekacin, teicoplanin, and vancomycin were the most active antibiotics with 100% susceptible rates in our study. Our study revealed that erythromycin and gentamicin were more antimicrobial effective in invasive disease than in noninvasive disease significantly. Methicillin-resistant Staphylococcus aureus infection spreads worldwide easily and inadequate use of antibiotics contributes to uptake of their new antimicrobial resistance. Continuous antimicrobial surveys are need for guiding policy on the adequate use of antibiotics to reduce the morbidity and mortality.

Cite this paper

Minami, M. , Sakakibara, R. , Imura, T. , Morita, H. , Kanemaki, N. and Ohta, M. (2015) Clinical Characteristics of Invasive Methicillin-Resistant Staphylococcus aureus at General Hospital in the Central Region of Japan from July 2014 to June 2015. Journal of Biosciences and Medicines, 3, 9-14. doi: 10.4236/jbm.2015.39002.


[1] Iwamoto, M., Mu, Y., Lynfield, R., Bulens, S.N., Nadle, J., Aragon, D., et al. (2013) Trends in Invasive Methicillin-Resistant Staphylococcus aureus Infections. Pediatrics, 132, e817-e824.
[2] Klevens, R.M., Morrison, M.A., Nadle, J., Petit, S., Gershman, K., Ray, S., et al., Active Bacterial Core surveillance (ABCs) MRSA Investigators (2007) Invasive Methicillin-Resistant Sta-phylococcus aureus Infections in the United States. JAMA, 298, 1763-1771.
[3] Barber, M. (1961) Methicillin-Resistant Staphylococci. Journal of Clinical Pathology, 14, 385-393.
[4] Diekema, D.J., Pfaller, M.A., Schmitz, F.J., Smayevsky, J., Bell, J., Jones, R.N., et al., SENTRY Partcipants Group (2001) Survey of Infections Due to Staphylococcus Species: Frequency of Occurrence and Antimicrobial Susceptibility of Isolates Collected in the United States, Canada, Latin America, Europe, and the Western Pacific Region for the SENTRY Antimicrobial Surveillance Program, 1997-1999. Clinical Infectious Disease, 32, S114-S132.
[5] Hartman, B. and Tomasz, A. (1981) Altered Penicillin-Binding Proteins in Me-thicillin-Resistant Strains of Staphylococcus aureus. Antimicrobial Agents and Chemotherapy, 19, 726-735.
[6] Katayama, Y., Ito, T. and Hiramatsu, K. (2000) A New Class of Genetic Element, Staphylococcus Cassette Chromosome Mec, Encodes Methicillin Resistance in Staphylococcus aureus. Anti-microbial Agents and Chemotherapy, 44, 1549-1555.
[7] Shorr, A.F. (2007) Epidemiology of Staphylococcal Resistance. Clinical Infectious Disease, 45, S171-S176.
[8] Otto, M. (2012) MRSA Virulence and Spread. Cellular Microbiology, 14, 1513-1521.
[9] Clinical and Laboratory Standards Institute (CLSI) (2014) Performance Standards for Antimicrobial Susceptibility Testing: 24st Informational Supplement. Clinical and Laboratory Standards Institute M100-S24, Wayne.
[10] Jean, S.S. and Hsueh, P.R. (2011) High Burden of Antimicrobial Re-sistance in Asia. International Journal of Antimicrobial Agents, 37, 291-295.
[11] Song, J.H., Hsueh, P.R., Chung, D.R., Ko, K.S., Kang, C.I. and Peck, K.R., et al., ANSORP Study Group (2011) Spread of Methicillin-Resistant Staphylococcus aureus between the Community and the Hospitals in Asian Countries: An ANSORP Study. Journal of Antimicrobial Chemotherapy, 66, 1061-1069.
[12] Kondo, S. (1994) Development of Arbekacin and Synthesis of New Derivatives Stable to Enzymatic Modifications by Methicillin-Resistant Staphylococcus aureus. Japanese Journal of Antibiotics, 47, 561-574.
[13] Tanaka, N., Matsunaga, K., Hirata, A., Matsuhisa, Y. and Nishimura T. (1983) Me-chanism of Action of Habekacin, a Novel Amino Acid Containing Aminoglycoside Antibiotic. Antimicrobial Agents and Chemotherapy, 24, 797-802.
[14] Matsumoto, T. (2014) Arbekacin: Another Novel agent for Treating In-fections Due to Methicillin-Resistant Staphylococcus aureus and Multidrug-Resistant Gram-Negative Pathogens. Clinical Pharmacology, 6, 139-148.
[15] Watanabe, T., Ohashi, K., Matsui, K. and Kubota, T. (1997) Comparative Studies of the Bactericidal, Morphological and Post-Antibiotic Effects of Arbekacin and Vancomycin against Methicil-lin-Resistant Staphylococcus aureus. Journal of Antimicrobial Chemotherapy, 39, 471-476.
[16] Maltezou, H.C. and Giamarellou, H. (2006) Community-associated methi-cillin-resistant Staphylococcus aureus infections.International Journal of Antimicrobial Agents, 27, 87-96.
[17] Kluytmans-Vandenbergh, M.F. and Kluytmans, J.A. (2006) Community-Associated Methicillin-Resistant Staphylococcus aureus: Current Perspectives. Clinical Microbiology and Infection, 12, 9-15.
[18] Motoshima, M., Yanagihara, K., Morinaga, Y., Matsuda, J., Sugahara, K, Yamada, Y., et al. (2010) Genetic Diagnosis of Community-Associated MRSA: A Multiplex Real-Time PCR Method for Staphylococcal Cassette Chromosome Mec Typing and Detecting Toxin Genes. Tohoku Journal of Experimental Medicine, 220, 165-170.
[19] Yamaguchi, T., Nakamura, I., Chiba, K. and Matsumoto, T. (2012) Epi-demiological and Microbiological Analysis of Community-Associated Methicillin-Resistant Staphylococcus aureus Strains Isolated from a Japanese Hospital. Japanese Journal of Infectious Disease, 65, 175-178.
[20] Kang, C.I. and Song, J.H. (2013) Antimicrobial Resistance in Asia: Current Epidemiology and Clinical Implications. Infection & Chemotherapy, 45, 22-31.

comments powered by Disqus

Copyright © 2018 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.